Mapping Better Outcomes in Advanced NSCLC: The Patient Experience

  • Official Sponsored Satellite Symposium @ European Cancer Congress #ECC2015
    Vienna, 27th September 2015 

    The highlights report of this symposium, including video presentations, is now available to download. Click the cover to read the report in a new window.


    Topics covered:
    Welcome and introduction – Nicholas Thatcher (UK)
    Mapping the road: new treatment options in sqNSCLC – Niels Reinmuth (Germany)
    Rerouting to response: overcoming resistance Cesare Gridelli (Italy)
    The open road: future therapeutic options in NSCLC Georgio Scagliotti (Italy)

  • From the Chair

    Welcome to Vienna and thank you for attending this European Cancer Congress satellite symposium entitled ‘Mapping Better Outcomes in Advanced Nsclc: The Patient Experience’, which we hope you will find engaging and useful.

    The beautiful city of Vienna is famous for its art, culture and architecture. It is also proud to contain the world-famous 650-year-old University of Vienna, which is home to one of the best museums dedicated to the history of Medicine, as well as being able to boast nine Nobel Prize Laureates for Science. World-renowned historical physicians have long come to Vienna to train and study, and many significant medical discoveries have occurred here.

    It is with this learning theme in mind that we hope today you gain a further understanding of the pathophysiology, challenges and treatment options within NSCLC.

    With several new treatment strategies having been developed, the aim of this symposium is to help guide you through the recommended treatment options available for patients who progress while on therapy for advanced NSCLC, and to become familiar with newly approved and advanced experimental treatment options within NSCLC.

    Our expert Faculty is looking forward to “walking you down this road” of where we currently are in the fast-moving world of treatment options, as well as exploring further the possibilities for the future. We are anticipating our panel discussion to be a lively and enlightening exchange amongst peers.

    We hope that you find this symposium an informative session and would be most grateful for your feedback via the evaluation form provided within this booklet.

  • Programme

    13:00 – 13:05
    Welcome and introduction
    Nicholas Thatcher (UK)

    13:05 – 13:30
    Mapping the road: new treatment options in sqNSCLC
    Niels Reinmuth (Germany)

    13:30 – 13:55
    Rerouting to response: overcoming resistance
    Cesare Gridelli (Italy)

    13:55 – 14:15
    The open road: future therapeutic options in NSCLC
    Georgio Scagliotti (Italy)

    14:15 – 14:30
    Panel discussion